Rearranged during transfection (RET) is a tyrosine kinase receptor proto-oncogene, point mutation of which underlies Multiple Endocrine Neoplasia Types 2A and 2B (MEN2A/MEN2B) and familial medullary thyroid cancer. This evidence concerns the gene RET and hereditary thyroid gland medullary carcinoma.